Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label, single-arm pharmacokinetic, safety and tolerability study of intravenous levetiracetam in children with epilepsy
2006-005722-23Phase 2Completed
- Sponsor
- UCB
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levetiracetam in epilepsy, sponsored by UCB. Primary endpoints: Safety and tolerability of intravenous levetiracetam and Pharmacokinetics of intravenous levetiracetam. Started Mar 2007; status: completed.
02
Drugs
levetiracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2006-005722-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005722-23.